Just One Lab Nerd
Contributor since: 2015
Latest Articles
Cel-Sci Corporation: The Arbitration Is On, But Is The Phase III Trial Off?
OpGen - A Play Against Multiple Antibiotic Resistant Infection Many May Not Have Noticed Before Its 100% Gain
What's Driving NanoViricides' Extreme Moves, And Second-Half Expectations
Can Hemispherx Get On Track After Its February Shake-Up?
A Closer Look At Cel-Sci Corporation Going Into Spring Of 2016
Are There Any Small Biotechnology Companies With An Answer To The Zika Virus Question?
Technical Breakthroughs, Clinical Trials, And Prospects For NanoViricides In 2016
Two Phase III Trials For The One Antibiotic? Can Achaogen's Plazomicin Antibiotic Deliver
Is International Stem Cell Corporation Finally Starting To Move Clinical Testing Forward?
Cel-Sci: Phase III Enrollment Numbers Announced, Arbitration Pushed Back, Diutive Financing
Interesting Developments For Cel-Sci's Upcoming Court-Date With Its Former CRO, InVentiv Clinical
Risks And Rewards For Cel-Sci: Phase III And Phase I Progress, And Arbitration
Risk Assessments For NanoViricides' Influenza And Herpes Virus Programs
Status Of The Pilot Production Plant Owned By NanoViricides: What This Means For Investors